ADMA Biologics Inc vs Arqit Quantum Inc — how do they compare? ADMA Biologics Inc trades at $9.87 (market cap $2.22B), while Arqit Quantum Inc trades at $23.77 (market cap $424.79M). The key difference: ADMA Biologics Inc is far larger — about 5.2× Arqit Quantum Inc's market cap. Which is the better fit depends on your goals.
| ADMA | ARQQ | |
|---|---|---|
Market Cap | $2.22B | $424.79M |
Sector | Health | Technology |
52-Week High | $20.38 | $58.27 |
52-Week Low | $7.60 | $11.78 |
Enterprise Value | $2.29B | $398.10M |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Arqit Quantum provides advanced cybersecurity software that uses symmetric key agreement technology. Its solutions protect networked devices and data against current and future cyber threats, including quantum attacks.
Read more on ARQQ →